findmyKOL

Kirsten Johansen, MD

Enriched profile

Director, Division of Nephrology, Hennepin Healthcare; President, Hennepin Healthcare Research Institute; Chief Research Officer, Hennepin Healthcare System; Professor of Medicine, University of Minnesota; Director, U.S. Renal Data System (USRDS) · Hennepin Healthcare

ORCIDNPI
Region🇺🇸 Minneapolis, MN · Midwest · United StatesSpecialtyNephrologyFocusDialysis and Renal Disease Management+4
Active KOLfindmyKOL typefindmyKOL type: our influence ranking, shown when you reveal the full profileLatest publication2022Online presenceNone verifiedPayments2021–2025NIH funding2018–2025

Kirsten Johansen is Director, Division of Nephrology, Hennepin Healthcare; President, Hennepin Healthcare Research Institute; Chief Research Officer, Hennepin Healthcare System; Professor of Medicine, University of Minnesota; Director, U.S. Renal Data System (USRDS) at Hennepin Healthcare. OpenAlex indexes 340 publications with 20,297 citations (h-index 73); ClinicalTrials.gov lists 2 registered studies with this person as an investigator. By OpenAlex citation count, this profile ranks in the top 5% of Nephrology profiles in the findmyKOL directory.

Data verified 14 Aug 2026

Overview

Updated 27 Aug 2026

Kirsten L. Johansen, MD, is Director, Division of Nephrology, Hennepin Healthcare. The public record shows 340 publications with 20,297 citations (h-index 73), centered on Dialysis and Renal Disease Management, Chronic Kidney Disease and Diabetes, Renal Transplantation Outcomes and Treatments. It also documents an investigator role on 2 registered clinical trials, industry payments reported by 6 companies, 5 NIH-funded awards (2018–2025).

  • Most recent indexed publication: 2022 · Kidney360
  • Top research focus: Dialysis and Renal Disease Management
  • 2 registered trials on ClinicalTrials.gov
  • Open Payments reporting from 6 companies

Generated from the cited public record · current as of 27 Aug 2026. Every fact links its source below.

Indications focus

from trials led + research topics
ESRD / Dialysis1 trialMuscle Weakness1 trialChronic Kidney Disease

Research focus

OpenAlex concept fingerprint
Dialysis and Renal Disease ManagementChronic Kidney Disease and DiabetesRenal Transplantation Outcomes and TreatmentsNutrition and Health in AgingAcute Kidney Injury Research

Drugs & molecules

across trials, industry payments and publications
Auryxiageneric · Ferric citrateClinical trialsIndustry payments1PublicationsImfinzigeneric · DurvalumabClinical trialsIndustry payments1PublicationsJesduvroqgeneric · DaprodustatClinical trialsIndustry payments1Publications

Works with

trial sponsors and companies reporting payments
GlaxoSmithKline, LLC.Clinical trialsIndustry payments28Akebia Therapeutics IncClinical trialsIndustry payments4National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Clinical trials2Industry payments

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
340publications

Distinct works indexed by OpenAlex, matched via ORCID; 5 in PubMed.

20,297citations

Total citations across indexed works.

73h-index

Hirsch index (OpenAlex). i10-index 217.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials
6companies · 2021–2025

Companies reporting payments to CMS. Facts, not judgments.

View payments
5NIH grants · 2018–2025

Federally funded research awards.

View funding

Contact

The practice address and phone this provider lists in the federal NPPES (CMS) registry.

Practice address

Telephone

Practice address and telephone from the federal NPPES registry.

Sign in to view contact details →

Clinical trials

Updated 27 Aug 2026

Listed as an investigator on 2 registered studies on ClinicalTrials.gov. The most recent:

Industry payments

Updated 27 Aug 2026

6 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:

Medicare prescribing footprint (2024)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    70.2%
    Loop diuretic18.5%
    Furosemide73%Torsemide28%
    Part D<11 patients
    Angiotensin receptor blocker (ARB)14.2%
    Losartan Potassium100%
    Part D14 patients
  • Metabolism & gastrointestinal

    10.9%
    Potassium supplement6.5%
    Potassium Chloride100%
    Part D<11 patients
    SGLT2 inhibitor4.4%
    Jardiance100%
    Part D<11 patients
  • Blood & clotting

    10.2%
    Solutions for parenteral nutrition10.2%
    Calcium Acetate100%
    Part D11 patients
2 more therapeutic areas behind the reveal.Reveal →
Where care is delivered (Part B)100% facility · 0% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

NIH funding

Updated 27 Aug 2026

5 NIH research awards on record, funded 20182025 per NIH RePORTER. The latest:

Publications

Updated 27 Aug 2026

Their five most recent publications, matched to their ORCID record and linked to PubMed.

Network

Updated 27 Aug 2026

The people this person publishes with most, by number of co-authored papers. Names link to their own profile when we have one.

Online presence

Updated 27 Aug 2026

This person's own public accounts first, then places where others mention them. Two different things, listed separately.

Mentions by others

where others cite or feature them
  • Other

    ajkdblog.org/2022/05/11/usrds-annual-data-report-2021-interview-with-dr-kirsten-johansen

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ajkdblog.org
  • Other

    arcforequity.ucsf.edu/events/kardos-renal-lecture-devastating-effect-covid-19-patients-end-stage-kidney-disease-kirsten-l

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →arcforequity.ucsf.edu

We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.

Background & recognition

Updated 27 Aug 2026

Credentials, appointments and honors, newest first, each linked to the public source it came from.

Education

degrees and training on record
  • MD

    Duke University School of Medicine

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hhrinstitute.org
  • Residency

    Internal Medicine, Massachusetts General Hospital

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hhrinstitute.org
  • Fellowship

    Nephrology, University of California, San Francisco

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hhrinstitute.org

Editorial & leadership roles

journal and society appointments
  • Director

    U.S. Renal Data System (USRDS), NIDDK/NIH-funded national ESRD data registry

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →hhrinstitute.org
  • Deputy Editor

    Clinical Journal of the American Society of Nephrology (CJASN)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →khrc.ucsf.edu

Awards & honors

honors on the public record
  • J. Michael Lazarus Award

    National Kidney Foundation (2021), for contributions to nephrology and renal replacement therapy research …

    2021
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →kidney.org

Secondary affiliations

appointments beyond the home institution
  • Professor of Medicine

    University of Minnesota Medical School

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ctsi.umn.edu
  • Hub Leadership Team member

    Clinical and Translational Science Institute (CTSI), University of Minnesota

    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ctsi.umn.edu
  • Co-Director

    Chronic Disease Research Group (CDRG)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →hhrinstitute.org
1 more affiliation behind the reveal.Reveal →

Media & interviews

press, podcasts and appearances
  • Profile interview

    "Excellence, Integrity and Collaboration," Minnesota Physician magazine, February 2026

    2026
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →mnphy.com
  • Interview

    "USRDS Annual Data Report 2021 Interview with Dr. Kirsten Johansen," AJKD Blog (American Journal of Kidney Diseases), May 2022

    2022
    verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →ajkdblog.org
  • Podcast guest

    Episode 28, "Racial and Ethnic Disparities at USRDS," GMO Dialogs (Fresenius Medical Care)

    provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →freseniusmedicalcare.com

Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.

Similar KOLs

Other experts from the same institution or the same specialty.